Craft capital management announces pricing of initial public offering for paxmedica, inc.

Shares will trade on nasdaq capital market under ticker symbol "pxmd" tarrytown, ny / accesswire / august 26, 2022 / paxmedica, inc. (nasdaq:pxmd), a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms, today announced the pricing of its initial public offering of 1,545,454 shares of its common stock at a public price of $5.25 per share. the gross proceeds to paxmedica from the offering, before deducting underwriting discounts, commissions and offering expenses, are expected to be approximately $8.1 million.
PXMD Ratings Summary
PXMD Quant Ranking